These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
64 related articles for article (PubMed ID: 13540171)
1. [The possibilities of treatment with cytostatics and antimetabolites]. LUHRS W Krebsarzt; 1958 Feb; 13(2):63-6. PubMed ID: 13540171 [No Abstract] [Full Text] [Related]
2. [The use of cytostatics in gynecological tumor therapy]. KEPP R; KOESTER H Med Monatsschr; 1962 Sep; 16():588-92. PubMed ID: 14032014 [No Abstract] [Full Text] [Related]
3. [Perspectives of medical therapy of solid tumours]. Koza I Vnitr Lek; 2001 Aug; 47(8):510-5. PubMed ID: 15633386 [TBL] [Abstract][Full Text] [Related]
4. [Drug therapy for inoperable gastric cancer: current possibilities and perspectives of development]. Volkov NM; Moiseenko VM Vopr Onkol; 2007; 53(4):383-92. PubMed ID: 17969398 [No Abstract] [Full Text] [Related]
5. [Cytostatics in general practice]. Høst H Tidsskr Nor Laegeforen; 1980 Feb; 100(5):267. PubMed ID: 7385147 [No Abstract] [Full Text] [Related]
6. [Do cytostatics interrupt wound healing]. KARRER K; WURNIG P Klin Med Osterr Z Wiss Prakt Med; 1958 May; 13(5):196-200. PubMed ID: 13550749 [No Abstract] [Full Text] [Related]
7. [Clinical experiences with the cytostatics E 39 & A 139]. OBRECHT P Munch Med Wochenschr; 1959 May; 101(20):901-6. PubMed ID: 13666768 [No Abstract] [Full Text] [Related]
8. [Chemotherapy of malignant neoplasms. VIII. The remaining cytostatics]. Beran M; Semonský M; Semonská S Cesk Farm; 1980 May; 29(3-4):106-5. PubMed ID: 7407946 [No Abstract] [Full Text] [Related]
9. [The present-day use of cytostatics in clinical and general practice]. Moeschlin S Med Klin; 1965 Jul; 60(30):1185-91. PubMed ID: 5320801 [No Abstract] [Full Text] [Related]
11. [The possibilities and limitations of modern cytostatic treatment of otorhinolaryngological tumors]. BOETTE G Z Laryngol Rhinol Otol; 1958 Nov; 37(11):707-11. PubMed ID: 13604630 [No Abstract] [Full Text] [Related]
12. New cytotoxic agents: a review of the literature. Hotta K; Ueoka H Crit Rev Oncol Hematol; 2005 Jul; 55(1):45-65. PubMed ID: 15927843 [TBL] [Abstract][Full Text] [Related]
13. [Cytostatics: occupational exposure and health risks]. Fransman W Tijdschr Diergeneeskd; 2007 Mar; 132(5):168-71. PubMed ID: 17378488 [No Abstract] [Full Text] [Related]
14. [Revisiting sensitization mechanisms in cancer thermochemotherapy]. Matsumoto H Fukuoka Igaku Zasshi; 2009 Apr; 100(4):95-103. PubMed ID: 19562936 [No Abstract] [Full Text] [Related]
15. [Treatment of non-muscle infiltrating tumours of the bladder]. Irani J Prog Urol; 2009 Apr; 19(4):248-53. PubMed ID: 19329037 [No Abstract] [Full Text] [Related]
16. Epigenetics of multiple myeloma after treatment with cytostatics and gamma radiation. Krejcí J; Harnicarová A; Streitová D; Hájek R; Pour L; Kozubek S; Bártová E Leuk Res; 2009 Nov; 33(11):1490-8. PubMed ID: 19362368 [TBL] [Abstract][Full Text] [Related]
17. [In vivo study of effects of some alkyl-phenyl-pyridinium compounds after their exposure to optical UV beams]. Pascu RA; Carstocea B; Voicu L; Ungureanu F; Gazdaru D; Trifu M; Dumitrescu M; Barbe J; Buliga S Oftalmologia; 2006; 50(1):107-10. PubMed ID: 16773950 [TBL] [Abstract][Full Text] [Related]
18. Treatment of Sézary syndrome with bexarotene after IFNalpha and methotrexate failure. Bagot M Dermatol Clin; 2008 Jan; 26 Suppl 1():27-9. PubMed ID: 18405184 [No Abstract] [Full Text] [Related]